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Dear Editor,
We read with great interest the recent article by Dr.
Gonzalez-Aguirre and colleagues entitled ‘‘Arms Down
Cone Beam CT Hepatic Angiography Performance
Assessment: Vascular Imaging Quality and Imaging Arte-
facts’’ [1]. One of the most important advantages of cone
beam CT (CBCT) is the possibility to evaluate the lesion’s
feeders assisting their identification and catheterization [2].
In this set, the patient’s arms positioning is crucial in order
not to impair CBCT imaging. Dr. Gonzalez-Aguirre et al.
had elegantly demonstrated that vessels’ visualization is
independent from the patient’s arms position, allowing to
perform the entire procedure without patient’s movements.
This minimizes the risk of contamination and reduces
procedural time.
However, literature shows that the major pivotal strength
of CBCT, either mono-phasic or possibly bi-phasic, is the
ability to depict in intra-procedurally ‘‘occult lesions’’, not
visible at pre-procedural second-line non-invasive imaging
(MRI, MDCT) [3]. This ability is not just for show, but yield
to some major clinical implications: the visualization of an
occult nodule identifies a subset of population experiencing
fast tumour growth, having consequences on the number of
adjunctive treatments controlling tumour growth (adjunctive
RFA, or TACE procedures) and prioritization for trans-
plantation [4]. Moreover, bi-phasic CBCT, with its unique
ability to intra-procedural permit nodule characterization,
could help in patients’ reclassification and real-time TACE
strategy modification [5].
In this light would be a crucial interest for the audience
to know whether the CBCT acquisition with arms down
does not alter the diagnostic performance of the modality
and ability of lesion’s characterization, especially for those
lesion localized peripherally, where the beam hardening
artefacts have been shown to be significant.
Finally, patient’s positioning is fundamental for CBCT
imaging. By acquiring the scan with patient’s arm down,
liver volume would not be located within the rotation iso-
centre. This could be a substantial limitation for lesion
located within the left liver lobe, eventually hypertrophied,
and for high BMI patients.
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